The Prime
ProGIGuard recently hosted a dynamic and memorable event where scientific and
clinically sound results supported the use of Saccharomyces cerevisiae CNCM I-3856 in abdominal symptomatic relief such as pain and generalised
discomfort. Members of the public and media were made aware of Irritable Bowel
Syndrome , or IBS, a common gastrointestinal disorder often unreported and
under diagnosed, and other associated conditions in IBD, or inflammatory bowel
disorders such as Crohn’s disease and ulcerative colitis, thanks to Professor
Pierre Desreumaux, an international gastroenterological expert based in France.
Over 800 million
people suffer as you do, from a condition known as IBS, or irritable bowel
syndrome. This gastrointestinal syndrome is a collection of symptoms as listed
above, and is diagnosed according to the Rome III criteria as recurrent
abdominal pain or discomfort (an uncomfortable sensation not described as pain)
for at least 3 days in a month in the last 3 months associated with 2 or more
of the following: improvement with defecation, onset associated with a change
in the frequency of stool, and the onset associated with a change in the
appearance of stool according to the Bristol stool chart.
3 different types of
IBS exist: IBS-C (IBS with constipation), IBS-D (IBS with diarrhoea), and IBS-M
(IBS with mixed constipation and diarrhoea). Other symptoms of IBS include
nausea, loss of bowel control, sudden urges to go to the bathroom and soiling.
IBS can affect
anyone, and up to as high as 21% of adults are affected in certain regions. More
women (70%) than men (30%) suffer IBS and all ages are affected, from teenagers
to the elderly. However IBS is most commonly found in the age groups 30 – 50
years old. Many people don’t even realise that this is a condition, with only
30% of sufferers consulting their doctors about this condition.
There are many
different remedies on the market, but only 8% of patients are satisfied with
their particular remedy. The syndrome affects patients both physically and
psychologically, impairing the patient’s ability to function emotionally,
socially and professionally.
IBS happens all over
the world, and an average of 15.6% of Malaysians suffer from IBS, with the
highest number of sufferers at greater than 20% in its respective country (the
USA for example). The global cost incurred for sufferers of IBS is estimated at
over USD$21 billion, including both the direct medical costs (physician visits,
investigative tests, drugs, etc.) and indirect costs (loss of productivity,
work absenteeism).
Professor Pierre Desreumaux
is passionate about all things gut related. He is Head of the Inflammatory
Digestive Diseases Research Unit at Lille University in France, and has been so
for seventeen years to date. As a medical doctor and PhD holder he is both a
skilled clinician and a top rated scientist, classified in the top 1% ranking
by ISI Web Science in 2010.
He gives approximately thirty oral presentations
every year and has done so ever since he became head of the unit in both
national and international congresses, and more than 200 publications reference
him in the medical data base PubMed. He is specially flown in to speak about
the role the special yeast probiotic Saccharomyces
cerevisiae CNCM I-3856 plays in relieving IBS as the active ingredient in
The Prime Pro GIGuard, a special formulation design to combat IBS.
One way to combat Irritable
Bowel Syndrome is to consume probiotics, a product readily available on the
market. However, The Prime ProGIGuard is the only yeast probiotic available on
the market, so that it can get rid of bad bacteria AND bad yeast, especially
harmful candida yeast that can enter
the bloodstream.
The Prime ProGIGuard
is safe and fast acting, and has strong scientific support and clinically
proven efficacy. Anyone from children aged two years and above can consume it,
and it is a breakthrough in gastrointestinal pain management.
The Prime ProGIGuard
has been clinically proven to relieve gastrointestinal symptoms, and is
suitable for anyone suffering from indigestion, food poisoning, food allergies
and/or food intolerance, constipation, diarrhoea, trapped wind and bloating,
overeating, anxiety, depression, stomach flu or even menstrual pain.
Studies have shown
that sufferers of gastrointestinal pain and discomfort experienced a
significant reduction in symptoms from the first week onwards of consumption
and especially within the first two weeks/15 days of consumption.
Saccharomyces
cerevisiae in The Prime ProGIGuard works in IBS by several ways.
One of the ways is that Saccharomyces cervisiae
CNCM I-3856 secretes saccharolytic enzymes and assisting intestinal flora
in generating short chain fatty acids that accelerates the bowel movements. It
also acts as a visceral analgesic, increasing resistance to pain by up to 40%. It
also acts as an anti-inflammatory to combat intestinal inflammation. It helps
rebalance the bacteria in the gut, being shown to reduce the harmful bacteria Enterococcus, E. coli and C. albicans. The
result is decreased inflammation, bloating, pain, discomfort, constipation
among relief of the other symptoms of IBS. It is indeed a wonder probiotic
(good yeast)!
The Prime ProGIGuard
retails for RM 66.80 for a bottle of 30 capsules and RM111.80 for a bottle of
60 capsules and is available at Guardian, Caring, AA and other leading
pharmacies nationwide. The Prime ProGIGuard is solely distributed by Cambert
(M) Sdn Bhd in Malaysia.
*For
more about Mouse Mommy Treats, do follow us*
